The American Food and Drug Administration (FDA) is expected to approve its grant later today Pfizer vaccine/BioNTech against Covid-19 for children aged 5 to 11 years, writes the New York Times, citing people with knowledge of the plans of the Organization.
This FDA decision – if it is indeed positive – will make this vaccine first against coronavirus approved for use in young children in the United States.
Approval is expected to make the Pfizer / BioNTech vaccine available to 28 million children Many of them will return to school for life in the next few days, Reuters reports.
The expected FDA approval comes three days after a committee The Agency’s special advisers voted overwhelmingly in favor the use of the Pfizer / BioNTech vaccine against Covid-19 for this solar group.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
